Literature DB >> 11336837

Intimin and the host cell--is it bound to end in Tir(s)?

G Frankel1, A D Phillips, L R Trabulsi, S Knutton, G Dougan, S Matthews.   

Abstract

Intimate bacterial adhesion to the intestinal epithelium is a pathogenic mechanism shared by several human and animal enteric pathogens, including enteropathogenic and enterohaemorrhagic Escherichia coli. Two bacterial protein partners involved in this intimate association have been identified, intimin and Tir. Some key remaining questions include whether intimin specifically interacts with one or more host-cell-encoded molecules and whether these contacts are a prerequisite for the subsequent intimate intimin-Tir association. Recent data support the hypothesis that the formation of a stable intimin-Tir relationship is the consequence of intimin protein interactions involving both host and bacterial components.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11336837     DOI: 10.1016/s0966-842x(01)02016-9

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  43 in total

1.  Verotoxin 2 enhances adherence of enterohemorrhagic Escherichia coli O157:H7 to intestinal epithelial cells and expression of {beta}1-integrin by IPEC-J2 cells.

Authors:  Bianfang Liu; Xianhua Yin; Yanni Feng; James R Chambers; Aiguang Guo; Joshua Gong; Jing Zhu; Carlton L Gyles
Journal:  Appl Environ Microbiol       Date:  2010-05-07       Impact factor: 4.792

2.  Interaction of enteropathogenic Escherichia coli with human intestinal mucosa: role of effector proteins in brush border remodeling and formation of attaching and effacing lesions.

Authors:  Robert K Shaw; Jennifer Cleary; Michael S Murphy; Gad Frankel; Stuart Knutton
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  Type V protein secretion pathway: the autotransporter story.

Authors:  Ian R Henderson; Fernando Navarro-Garcia; Mickaël Desvaux; Rachel C Fernandez; Dlawer Ala'Aldeen
Journal:  Microbiol Mol Biol Rev       Date:  2004-12       Impact factor: 11.056

Review 4.  Enteropathogenic and enterohemorrhagic Escherichia coli infections: translocation, translocation, translocation.

Authors:  Junkal Garmendia; Gad Frankel; Valérie F Crepin
Journal:  Infect Immun       Date:  2005-05       Impact factor: 3.441

5.  Polarity of enteropathogenic Escherichia coli EspA filament assembly and protein secretion.

Authors:  Valérie F Crepin; Robert Shaw; Cecilia M Abe; Stuart Knutton; Gad Frankel
Journal:  J Bacteriol       Date:  2005-04       Impact factor: 3.490

6.  EspF of enteropathogenic Escherichia coli binds sorting nexin 9.

Authors:  Oliver Marchès; Miranda Batchelor; Robert K Shaw; Amit Patel; Nicola Cummings; Takeshi Nagai; Chihiro Sasakawa; Sven R Carlsson; Richard Lundmark; Celine Cougoule; Emmanuelle Caron; Stuart Knutton; Ian Connerton; Gad Frankel
Journal:  J Bacteriol       Date:  2006-04       Impact factor: 3.490

7.  Isolation of recombinant antibodies against EspA and intimin of Escherichia coli O157:H7.

Authors:  Sarah A Kühne; William S Hawes; Roberto M La Ragione; Martin J Woodward; Garry C Whitelam; Kevin C Gough
Journal:  J Clin Microbiol       Date:  2004-07       Impact factor: 5.948

8.  Modelling of infection by enteropathogenic Escherichia coli strains in lineages 2 and 4 ex vivo and in vivo by using Citrobacter rodentium expressing TccP.

Authors:  Francis Girard; Valérie F Crepin; Gad Frankel
Journal:  Infect Immun       Date:  2009-02-02       Impact factor: 3.441

9.  Cortactin recruitment by enterohemorrhagic Escherichia coli O157:H7 during infection in vitro and ex vivo.

Authors:  Aurelie Mousnier; Andrew D Whale; Stephanie Schüller; John M Leong; Alan D Phillips; Gad Frankel
Journal:  Infect Immun       Date:  2008-08-04       Impact factor: 3.441

10.  The T3SS effector EspT defines a new category of invasive enteropathogenic E. coli (EPEC) which form intracellular actin pedestals.

Authors:  Richard Bulgin; Ana Arbeloa; David Goulding; Gordon Dougan; Valerie F Crepin; Benoit Raymond; Gad Frankel
Journal:  PLoS Pathog       Date:  2009-12-11       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.